Evidence map›Paper›PMID 42510714›Full record

ArticleBiology2026

Ligand Design Using Unique Conformations to Preferentially Dock a Specific Site on Collagen-Bound MMP1.

Anthony Nash, Chase Harms, Susanta K Sarkar

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Anthony NashSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85287, USA.
Chase HarmsSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85287, USA.
Susanta K SarkarSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0002-6858-6912

Funding

Allosteric control of collagen fibril degradation by matrix metalloprotease-1R01GM145210 · NIGMS · COLORADO SCHOOL OF MINES · PI SARKAR, SUSANTA KUMAR · 2022 to 2025
$1.2M
NIGMS NIH HHS R01 GM145210NIH HHS GM145210
6 · The paper itself

Abstract

Precise site-specific ligand design remains a major challenge in structure-based drug discovery. Most existing approaches screen ligands against binding pockets identified from static protein structures obtained by X-ray crystallography, NMR spectroscopy, cryo-electron microscopy, or AlphaFold predictions. However, protein function is governed by a structure-dynamics-function relationship, and ligand screening that does not account for binding competition across the protein surface or the receptor's dynamic, substrate-dependent conformational states remains incomplete. Substrate-specific conformations are underexplored and may offer new opportunities for selective ligand design, although systematic workflows to identify and exploit such states remain limited. Previously, we showed that collagen alters matrix metalloprotease-1 (MMP1) dynamics and that R405 is a collagen-specific allosteric residue exhibiting strong dynamic correlations with the catalytic site. Here, we present a computational framework for substrate-specific allosteric ligand design using collagen-bound MMP1 as a model system. We characterized the conformational dynamics of free and collagen-bound MMP1 by all-atom molecular dynamics simulations, clustered the resulting conformational ensembles, and identified conformations unique to the collagen-bound state. These conformations were used as structural templates for machine-learning-based generation of approximately 150,000 candidate ligands, which were subsequently docked against both the R405-centered region and all detectable binding pockets on the MMP1 surface. Several candidate ligands were predicted to dock preferentially at the R405 region by at least 0.3 kcal/mol compared with competing surface pockets. Together, these results establish a generalizable computational workflow for identifying candidate ligands predicted to preferentially dock to substrate-specific allosteric conformations and provide a foundation for future experimental validation of selective allosteric modulation.

Indexed as

collagenMMP1substrate-specific allosterysubstrate-specific drug design

Identifiers

PMID42510714
PMCPMC13403677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.